Search details
1.
CD4 T cells and toxicity from immune checkpoint blockade.
Immunol Rev
; 318(1): 96-109, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37491734
2.
In vivo identification of tumor- suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma.
Cell
; 147(2): 382-95, 2011 Oct 14.
Article
in English
| MEDLINE | ID: mdl-22000016
3.
GNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation.
Am J Hum Genet
; 99(2): 443-50, 2016 Aug 04.
Article
in English
| MEDLINE | ID: mdl-27476652
4.
A generic, cost-effective, and scalable cell lineage analysis platform.
Genome Res
; 26(11): 1588-1599, 2016 11.
Article
in English
| MEDLINE | ID: mdl-27558250
5.
Spitz nevi and Spitzoid melanomas: exome sequencing and comparison with conventional melanocytic nevi and melanomas.
Mod Pathol
; 30(5): 640-649, 2017 05.
Article
in English
| MEDLINE | ID: mdl-28186096
6.
Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.
J Transl Med
; 15(1): 236, 2017 11 16.
Article
in English
| MEDLINE | ID: mdl-29145885
7.
Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo.
J Immunol
; 194(3): 950-9, 2015 Feb 01.
Article
in English
| MEDLINE | ID: mdl-25539810
8.
RAC1P29S is a spontaneously activating cancer-associated GTPase.
Proc Natl Acad Sci U S A
; 110(3): 912-7, 2013 Jan 15.
Article
in English
| MEDLINE | ID: mdl-23284172
9.
Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate.
Proc Natl Acad Sci U S A
; 109(40): 16107-12, 2012 Oct 02.
Article
in English
| MEDLINE | ID: mdl-22988085
10.
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.
J Transl Med
; 12: 277, 2014 Oct 28.
Article
in English
| MEDLINE | ID: mdl-25348889
11.
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.
Proc Natl Acad Sci U S A
; 108(40): 16723-8, 2011 Oct 04.
Article
in English
| MEDLINE | ID: mdl-21933959
12.
Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction.
medRxiv
; 2024 Jan 22.
Article
in English
| MEDLINE | ID: mdl-38260271
13.
Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma.
J Immunother Cancer
; 12(3)2024 03 21.
Article
in English
| MEDLINE | ID: mdl-38519058
14.
Interferon-stimulated neutrophils as a predictor of immunotherapy response.
Cancer Cell
; 42(2): 253-265.e12, 2024 02 12.
Article
in English
| MEDLINE | ID: mdl-38181798
15.
Circulating Tumor Reactive KIR+CD8+ T cells Suppress Anti-Tumor Immunity in Patients with Melanoma.
Res Sq
; 2024 Feb 28.
Article
in English
| MEDLINE | ID: mdl-38464315
16.
Dynamic changes of circulating soluble PD-1/PD-L1 and its association with patient survival in immune checkpoint blockade-treated melanoma.
Int Immunopharmacol
; 118: 110092, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37004344
17.
Unannotated microprotein EMBOW regulates the interactome and chromatin and mitotic functions of WDR5.
Cell Rep
; 42(9): 113145, 2023 09 26.
Article
in English
| MEDLINE | ID: mdl-37725512
18.
Integrated analysis of tumor samples sheds light on tumor heterogeneity.
Yale J Biol Med
; 85(3): 347-61, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-23012583
19.
Integrative molecular and clinical profiling of acral melanoma links focal amplification of 22q11.21 to metastasis.
Nat Commun
; 13(1): 898, 2022 02 23.
Article
in English
| MEDLINE | ID: mdl-35197475
20.
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma.
Nat Med
; 28(2): 353-362, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35027754